Detalhe da pesquisa
1.
RIG-I and Other RNA Sensors in Antiviral Immunity.
Annu Rev Immunol
; 36: 667-694, 2018 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29677479
2.
RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.
Cell
; 169(2): 301-313.e11, 2017 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28366204
3.
The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons.
Immunity
; 50(1): 64-76.e4, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635240
4.
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature
; 584(7821): 443-449, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668443
5.
A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
J Immunol
; 210(9): 1247-1256, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939421
6.
Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease.
Immunity
; 36(1): 120-31, 2012 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22284419
7.
Immune signaling by RIG-I-like receptors.
Immunity
; 34(5): 680-92, 2011 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21616437
8.
Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells.
J Immunol
; 201(10): 3036-3050, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297339
9.
Class A Scavenger Receptor-Mediated Double-Stranded RNA Internalization Is Independent of Innate Antiviral Signaling and Does Not Require Phosphatidylinositol 3-Kinase Activity.
J Immunol
; 195(8): 3858-65, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26363049
10.
Membrane Perturbation-Associated Ca2+ Signaling and Incoming Genome Sensing Are Required for the Host Response to Low-Level Enveloped Virus Particle Entry.
J Virol
; 90(6): 3018-27, 2015 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719279
11.
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
J Virol
; 90(5): 2372-87, 2015 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26676770
12.
Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.
J Virol
; 88(3): 1582-90, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24257594
13.
Convergent evolution of escape from hepaciviral antagonism in primates.
PLoS Biol
; 10(3): e1001282, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22427742
14.
Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.
PLoS Pathog
; 8(8): e1002839, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22912574
15.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure
; 32(2): 131-147.e7, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157856
16.
Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses.
J Virol
; 86(13): 7334-44, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22532686
17.
Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.
J Virol
; 86(18): 9888-98, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22761364
18.
Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection.
J Allergy Clin Immunol
; 130(5): 1187-1196.e5, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22981788
19.
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies.
MAbs
; 15(1): 2152526, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476037
20.
A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques.
Sci Transl Med
; 14(665): eabo6160, 2022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857623